Li Yan

1.3k total citations
54 papers, 872 citations indexed

About

Li Yan is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li Yan has authored 54 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Yan's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Colorectal Cancer Surgical Treatments (3 papers). Li Yan is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Colorectal Cancer Surgical Treatments (3 papers). Li Yan collaborates with scholars based in China, United States and United Kingdom. Li Yan's co-authors include Weijing Sun, Eriko Katsuta, Kazuaki Takabe, Jin Gu, Guangmin Xia, Zhiguo Chen, Qi Wang, Hongwei Wang, Tong Wang and Lijuan Qu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Li Yan

53 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Yan China 18 393 336 206 178 83 54 872
Adriana L. Gonzalez United States 17 722 1.8× 349 1.0× 221 1.1× 284 1.6× 61 0.7× 25 1.1k
Jianya Zhou China 16 364 0.9× 391 1.2× 189 0.9× 376 2.1× 51 0.6× 74 898
Huan Yan China 21 763 1.9× 209 0.6× 302 1.5× 98 0.6× 64 0.8× 38 1.3k
Haitao Chen China 16 445 1.1× 357 1.1× 190 0.9× 210 1.2× 64 0.8× 56 969
Xiaojing Cheng China 19 690 1.8× 352 1.0× 312 1.5× 211 1.2× 107 1.3× 57 1.3k
Lisa Vanderveer United States 22 816 2.1× 297 0.9× 238 1.2× 98 0.6× 67 0.8× 29 1.3k

Countries citing papers authored by Li Yan

Since Specialization
Citations

This map shows the geographic impact of Li Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yan more than expected).

Fields of papers citing papers by Li Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yan. The network helps show where Li Yan may publish in the future.

Co-authorship network of co-authors of Li Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Li Yan. A scholar is included among the top collaborators of Li Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Yan. Li Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dongfang, Siwen Gui, Juncai Pu, et al.. (2025). PsycGM: a comprehensive database for associations between gut microbiota and psychiatric disorders. Molecular Psychiatry. 30(9). 4222–4233. 1 indexed citations
2.
Kang, Ning, et al.. (2024). Oral microbiota dysbiosis alters chronic restraint stress-induced depression-like behaviors by modulating host metabolism. Pharmacological Research. 204. 107214–107214. 9 indexed citations
3.
Roy, Arya Mariam, et al.. (2024). Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression. Breast Cancer Research and Treatment. 208(2). 321–331. 3 indexed citations
5.
You, Weiqiang, Nengquan Sheng, Li Yan, et al.. (2019). The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers. Journal of Cancer. 10(16). 3757–3766. 22 indexed citations
6.
Takahashi, Hideo, Eriko Katsuta, Li Yan, Subhamoy Dasgupta, & Kazuaki Takabe. (2019). High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma. Surgery. 166(2). 150–156. 35 indexed citations
7.
Xiao, Peipei, Ying Zhou, Jing Lu, et al.. (2019). HIV-1 genotype diversity and distribution characteristics among heterosexually transmitted population in Jiangsu province, China. Virology Journal. 16(1). 51–51. 12 indexed citations
8.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2018). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. PMC. 1 indexed citations
9.
Yan, Li, et al.. (2018). Effect of medical insurance and enteric preferential policies on complications of colonoscopy in colorectal cancer screening.. 18(3). 340–344. 2 indexed citations
10.
Wang, Weili, Lei Huang, Jian‐Yue Jin, et al.. (2017). IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Research. 78(3). 809–816. 54 indexed citations
11.
Meng, Chen, Taiyong Quan, Zhongyi Li, et al.. (2017). Transcriptome profiling reveals the genetic basis of alkalinity tolerance in wheat. BMC Genomics. 18(1). 24–24. 39 indexed citations
12.
Dashevsky, Brittany Z., Chenpeng Zhang, Li Yan, et al.. (2017). Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation. SHILAP Revista de lepidopterología. 1(1). 8–8. 5 indexed citations
13.
Sun, Weijing & Li Yan. (2016). Gastric cancer: current and evolving treatment landscape. Chinese Journal of Cancer. 35(1). 83–83. 43 indexed citations
14.
Morán, Teresa, Enriqueta Felip, Vicki L. Keedy, et al.. (2014). Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial. Experimental Hematology and Oncology. 3(1). 26–26. 27 indexed citations
15.
Yan, Li, et al.. (2013). The heterologous expression in Arabidopsis thaliana of sorghum transcription factor SbbHLH1 downregulates lignin synthesis. Journal of Experimental Botany. 64(10). 3021–3032. 44 indexed citations
16.
Zhou, Yang, Li Li, Zigang Xu, et al.. (2012). Efficacy and safety of propranolol in treating infantile hemangiomas. Chinese Journal of Dermatology. 45(7). 466–469. 1 indexed citations
17.
Yan, Li, Shuwei Liu, Shuangyi Zhao, et al.. (2012). Identification of differentially expressed genes in sorghum (Sorghum bicolor) brown midrib mutants. Physiologia Plantarum. 146(4). 375–387. 13 indexed citations
18.
Wang, Qi, Jing Shen, Zhenfu Li, et al.. (2009). Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer. 9(1). 287–287. 21 indexed citations
19.
Wang, Qi, et al.. (2009). Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer. Histopathology. 55(3). 284–293. 66 indexed citations
20.
Yan, Li. (2008). The Value of Tumor Marker Biochip Diagnostic System C12 in the Diagnosis and Monitor of Gastric Cancer. Clinical Oncology and Cancer Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026